Expression characteristics of 123Ivascular endothelial growth factorbinding sites on tumor cells
CHEN Wen-Biao, LI Shu-Ren, QI Su-Wen, CHEN De-Hang, DAI Yong
2014, 41 (4):
297-301.
doi: 10.3760/cma.j.issn.1673422X.2014.04.018
ObjectiveTo explore the expression characteristics of vascular endothelial growth factor (VEGF) receptor (VEGFR). MethodsThe 123IVEGF165 and 123IVEGF121 were marked to human umbilical vein endothelial cell (HUVEC), several human tumor cell lines (HMC1, A431, KU812, U937, HEP1, HEPG2, HEP3B and Raji), a variety of human tumors and adjacent nonneoplastic tissues as well as peripheral blood cells. Then, the specific binding site maximal binding capacity (Bmax), dissociation constant (Kd) and concentration of 50% required specific binding (IC50) were analyzed. The affinity, quantity and specificity of different cells combined with 123IVEGF165 and 123IVEGF121 were judged. ResultsTwo kinds of analogous 123IVEGF165 binding sites on the surface of HUVEC were found. While, there was only one kind of 123IVEGF121 binding site.123IVEGF121 was found on the special cell lines (HUVEC, HEP1 and HMC1) and special early tumors (early melanoma, ductal breast cancer, ovarian cancer and meningioma). Compared with peripheral blood cells and adjacent nonneoplastic tissues, the number of VEGFR of tumor cells was bigger. Among the 123IVEGF165 marked VEGFR, the Bmax value of early melanoma, ductal breast cancer, hepatocellular carcinoma, papillary thyroid carcinoma, ovarian carcinoma, renal cell carcinoma were 45±13, 13±3, 25±8, 5±2, 42±12, 20±6, respectively. While among the 123IVEGF121 marked VEGFR, the Bmax value of early melanoma, ductal breast cancer, ovarian carcinoma were 30±8, 8±3, 20±6. 123IVEGF165 and 123IVEGF121 had specific binding capacity with a variety of human tumor cells and tissues. Compared with 123IVEGF121, there were more different kinds of tumor cells could be bound to 123IVEGF165 with higher capacity. Conclusion123IVEGF165 may be a potential target of tumor imaging in vivo, and it is expected to be used to diagnose and treat tumors.
Related Articles |
Metrics
|